BeOne Medicines (ONC) EBIT Margin Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 530.00 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -1,211.00 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 6,993.00 |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 9,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,942.00 |
| Dec 31, 2025 | 13,564.00 |
| Sep 30, 2025 | 12,464.00 |
| Jun 30, 2025 | 13,532.00 |
| Mar 31, 2025 | 14,556.00 |
| Dec 31, 2024 | -9,610.00 |
| Sep 30, 2024 | 21,194.00 |
| Jun 30, 2024 | 30,504.00 |
| Mar 31, 2024 | -4,635.00 |
| Dec 31, 2023 | 42,393.00 |
| Sep 30, 2023 | 46,610.00 |
| Jun 30, 2023 | 49,323.00 |
| Mar 31, 2023 | 63,504.00 |
| Dec 31, 2022 | 55,877.00 |
| Sep 30, 2022 | 50,969.00 |
| Jun 30, 2022 | -7,142.00 |
| Mar 31, 2022 | 7,867.00 |
| Dec 31, 2021 | 56,768.00 |
| Sep 30, 2021 | 5,482.00 |
| Jun 30, 2021 | -779.00 |
| Mar 31, 2021 | 35,207.00 |
| Dec 31, 2020 | 8,671.00 |
| Sep 30, 2020 | -53,542.00 |
| Jun 30, 2019 | 620,944.00 |
| Mar 31, 2019 | 278,030.00 |
| Dec 31, 2018 | 8,533.00 |
| Sep 30, 2018 | 73,514.00 |
| Jun 30, 2018 | 16,694.00 |
| Mar 31, 2018 | 37,104.00 |